Drug Profile
R 1628
Alternative Names: AM-102 - Roche; R-1628Latest Information Update: 07 Apr 2011
Price :
$50
*
At a glance
- Originator Roche
- Developer Amira Pharmaceuticals; Roche
- Class
- Mechanism of Action P38 mitogen-activated protein kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Psoriasis; Rheumatoid arthritis
Most Recent Events
- 25 May 2004 Preclinical trials in Rheumatoid arthritis (PO)